Table 4.
Deduced amino acid substitutions for CxFV by genotype in the E gene
| Genotype1 | Residue2 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E-60 | E-64 | E-117 | E-125 | E-185 | E-236 | E-326 | E-340 | E-381 | E-407 | E-414 | E-423 | |
| G1 | V (Val) | F (Phe) | G (Gly) | I (Ile) | H (His) | V (Val) | R (Arg) | V (Val) | H (His) | F (Phe) | F (Phe) | V (Val) |
| G2 | A3 (Ala) | Y (Tyr) | E (Glu) | I (Ile) | Y (Tyr) | I (Ile) | K (Lys) | I (Ile) | Y (Tyr) | L (Leu) | F (Phe) | I (Ile) |
| SDDM06-11 | V (Val) | F (Phe) | G (Gly) | V (Val) | H (His) | V (Val) | R (Arg) | I (Ile) | H (His) | L (Leu) | V (Val) | I (Ile) |
1G1: Japan and Indonesia, USA:TX/Iowa; G2: Uganda, Guatemala, Mexico, West Indies;
2 Amino acid positions are determined from the sequence alignment of the completely E sequenced isolates of CxFV.
3 Boldface indicates deduced amino acid specific to that genotype.